.view-toggle-wrapper { display: none; } #content-overview { display: block !important; } #content-technical { display: block !important; margin-top: 50px; border-top: 2px solid #ccc; padding-top: 30px; }

Use the toggle to switch between the simple Overview and the Technical Data content.

Goldenseal (Hydrastis canadensis): Uses, Safety, and What to Know

Overview

Plain-English information for everyday use

1. What Is Goldenseal?

Key Takeaway

Goldenseal is a traditional North American woodland herb whose yellow root contains berberine and hydrastine. It's important to know two things up front: its main compound (berberine) is barely absorbed when swallowed, and it has real safety cautions — including that it must be avoided entirely in pregnancy and breastfeeding.

Goldenseal is the common name for Hydrastis canadensis, a low-growing woodland plant in the buttercup family (Ranunculaceae) native to eastern North America. The medicinal part is the bright-yellow root and underground stem — which is why old names for it include orangeroot, yellowroot, and yellow puccoon. IARC. Hydrastis canadensis monograph. Open Source ↗

Its main active compounds are plant alkaloids — chiefly berberine (which gives the root its yellow color) and hydrastine, plus a little canadine. One important point: berberine is not unique to goldenseal — it's also found in barberry, Oregon grape, and other plants. Hydrastine and canadine are the compounds that actually identify true goldenseal. IARC. Hydrastis canadensis monograph. Open Source ↗

It's sold as capsules and tablets (the most common forms), liquid tinctures, and topical products, and is classically combined with echinacea in "cold-season" products. As you'll see below, goldenseal is one of the few herbs where the safety and drug-interaction information matters more than the list of marketed uses. NCCIH. Goldenseal. Open Source ↗

Key Highlights

A North American woodland herb (Hydrastis canadensis); the yellow root is used
Main compounds: berberine and hydrastine (berberine is shared with other plants)
Very little berberine is absorbed when swallowed — so it is not the same as a berberine supplement
Its best-proven effect in people is that it changes how the body handles many medicines
Must be avoided entirely in pregnancy, breastfeeding, and infants (see Section 3)
It is a threatened wild plant — sourcing matters (see Section 10)

2. Why People Take Goldenseal

Key Takeaway

People reach for goldenseal for colds and "immune support," as a "natural antibiotic," for digestion, and because of berberine's reputation for blood sugar. Honestly, most of these are unproven for goldenseal — and a couple are outright myths. It's worth knowing what the evidence actually says before you start.

Goldenseal is marketed for a wide range of reasons. The most common include: NCCIH. Goldenseal. Open Source ↗

Colds, sinus issues, and general "immune support"
As a "natural antibiotic" or for digestive complaints
The hope that it delivers berberine's much-talked-about effect on blood sugar
The widespread belief that it can help "pass" or "mask" a drug test
Topical or traditional uses for the skin, mouth, or eyes

Here's the honest part: most of these reasons are not specific to anything goldenseal is proven to do, and several do not hold up. The "drug-test masking" idea is a myth (Section 6); the blood-sugar hope comes from berberine, but so little berberine is absorbed from goldenseal that those effects do not transfer; and the "immune/cold" use is not supported by good studies. No single herb taken alone is a substitute for proven care. Goldenseal is a traditional herb, not a remedy for any specific health problem — and unlike many herbs it has serious cautions, so please read Section 3 and talk with your healthcare provider before using it.

3. Who Should Avoid It or Be Careful

Key Takeaway

Goldenseal must be avoided completely in pregnancy, breastfeeding, and in babies, and by people with an inherited red-blood-cell condition. Be very careful — and check with your provider — if you take almost any prescription medicine, because goldenseal can change how your body handles it.

Do not use goldenseal at all if any of these apply:

You are pregnant, breastfeeding, or it would be used on a baby or newborn. This is a strict "no" — see the box below for why.
You have an inherited red-blood-cell condition (an inherited condition affecting red blood cells). Goldenseal's berberine can cause red blood cells to break down. IARC. Hydrastis canadensis monograph. Open Source ↗
You take a medicine with a narrow safety margin — for example anti-rejection medicines after a transplant (such as cyclosporine), blood thinners, or certain heart medicines. Goldenseal can raise their levels. Wu X, et al. Eur J Clin Pharmacol. 2005. Open Source ↗

Talk with your healthcare provider before using it — and in many cases avoid it — if you:

Take any prescription medicine. Goldenseal slows down two of the body's main drug-processing enzymes, which can raise the levels of many medicines. This is its most important real-world effect. Gurley BJ, et al. Clin Pharmacol Ther. 2008. Open Source ↗
Take a medicine for blood sugar. Goldenseal may change how it works, so monitor and coordinate with your provider. Mandal SK, et al. Pharmacol Res. 2020. Open Source ↗
Have a heart or blood-pressure condition, a condition that causes convulsions, a bleeding problem, or liver or kidney problems.
Have surgery coming up — stop goldenseal at least one to two weeks beforehand.

If You're Pregnant or Breastfeeding

P-X — Avoid entirely (do not use) Breast-milk transfer: T-U (unknown)

Pregnancy: Do not use goldenseal in pregnancy. It can stimulate the uterus (it has a traditional reputation for bringing on menstruation and ending pregnancy), and — most importantly — one of its compounds, berberine, can push a substance called bilirubin out of its safe binding in the blood. In a baby, that can cause a dangerous form of newborn jaundice that may lead to permanent brain injury. This risk is serious enough that goldenseal is considered off-limits in pregnancy. Chan E. Biol Neonate. 1993. Open Source ↗

Breastfeeding: Do not use goldenseal while breastfeeding. The same newborn-jaundice concern applies, and goldenseal should never reach a baby. There's a documented infant death after goldenseal was applied to a baby's umbilical-cord area — so it must not be used on or around infants in any form. Bring any questions to your pediatrician. Drugs and Lactation Database (LactMed). Open Source ↗

Discontinue and Seek Medical Attention If:

You notice yellowing of the skin or eyes (jaundice), dark urine, or unusual tiredness.
You feel faint or notice your heartbeat is unusually slow, fast, or irregular.
You have an allergic reaction (rash, swelling, trouble breathing) or, with a topical product, a skin reaction where it's applied.
You experience confusion, twitching, or any severe reaction — and for any large accidental dose, contact Poison Control (1-800-222-1222).

4. Using It Sensibly

Key Takeaway

Given the weak evidence and the real cautions, "using it sensibly" mostly means using it carefully: keep courses short, tell your provider about every medicine you take, choose a third-party-tested product, and never use it on babies or as a homemade eyewash.

If You Choose to Use Goldenseal

Tell your provider and pharmacist about every medicine and supplement you take. The interaction risk is goldenseal's biggest real-world issue — this single step matters most. Gurley BJ, et al. Mol Nutr Food Res. 2008. Open Source ↗
Keep courses short. Goldenseal is traditionally used for no more than about three weeks at a time, with breaks. NCCIH. Goldenseal. Open Source ↗
Choose a tested product. Goldenseal is frequently mislabeled or substituted with cheaper plants, and some products have contained lead — so third-party testing matters (Section 10). Wallace ED, et al. Food Chem Toxicol. 2018. Open Source ↗
Never use it on or around a baby, and never make a homemade eyewash or eye drops — the eye uses carry a real risk of contamination and injury.
Don't expect berberine's effects. If you're interested in berberine specifically (for example for blood sugar), goldenseal is not the way to get it — talk to your provider about that separately.
Choose sustainably sourced goldenseal (forest-grown or cultivated), because wild goldenseal is threatened (Section 10).

5. Side Effects

Key Takeaway

At normal doses, side effects are usually mild (stomach upset). High doses can cause serious effects on the nervous system, breathing, and heart. The most important risks are the danger to babies and the way goldenseal changes the levels of other medicines.

At customary doses, most reported side effects are mild and uncommon — nausea, stomach upset, or a change in bowel habits, and occasionally a rash. NCCIH. Goldenseal. Open Source ↗

The effects that matter most are the serious ones:

Danger to babies (the most serious): berberine can cause a dangerous form of newborn jaundice — the reason goldenseal must never be used in pregnancy, breastfeeding, or on infants (Section 3). Chan E. Biol Neonate. 1993. Open Source ↗
High-dose effects: very high amounts have been linked to convulsions, confusion, slowed breathing, and effects on blood pressure and heart rate. IARC. Hydrastis canadensis monograph. Open Source ↗
Effects on other medicines: by raising the levels of many medicines, goldenseal can cause side effects from those medicines (Section 11). Gurley BJ, et al. Clin Pharmacol Ther. 2008. Open Source ↗
Skin and sun: allergic skin reactions and increased sun sensitivity have been reported.

You may have read that goldenseal causes a particular concern in animal studies. To be straight about it: in a long-term study where animals were fed very high doses, goldenseal was linked to growths in the liver. Researchers found it did not damage DNA, the doses were far higher than any human would use, and goldenseal is not listed as causing this effect in people — but it's another reason not to take high doses for long periods. IARC. Hydrastis canadensis monograph. Open Source ↗

6. What Research Suggests

Key Takeaway

The one thing well-established in people is that goldenseal changes how the body processes medicines — useful to know for safety, but not a health benefit. The popular uses (colds, "immune support") aren't supported, and the drug-test idea is a myth.

The well-proven effect (a safety issue, not a benefit). The best-established thing about goldenseal in humans is that it significantly slows two key drug-processing enzymes. In careful studies it raised the blood level of a test medicine, and in a controlled trial in transplant patients it raised levels of an anti-rejection medicine. This is genuinely important — but it's a reason for caution, not a benefit. Gurley BJ, et al. Mol Nutr Food Res. 2008. Open Source ↗ Wu X, et al. Eur J Clin Pharmacol. 2005. Open Source ↗

The berberine confusion. Many claims for goldenseal are really claims about berberine (for blood sugar, for example). But oral berberine is barely absorbed — under 1% — and a goldenseal capsule contains only a small amount of it. To reach the berberine doses used in studies, you'd have to take an impractical number of capsules. So berberine's studied effects do not carry over to ordinary goldenseal use. Mandal SK, et al. Pharmacol Res. 2020. Open Source ↗

Popular uses that aren't supported. For the common cold and "immune support," independent reviewers find the evidence insufficient — there are no rigorous human studies showing it helps. And the long-standing belief that goldenseal can "mask" a drug test is a myth that traces back to a 1900 novel; modern labs can actually detect goldenseal in urine. NCCIH. Goldenseal. Open Source ↗

Its local, traditional uses (as a bitter for digestion, or applied as an antiseptic) are biologically plausible because berberine has antibacterial activity in the lab — but they have not been proven in good human studies. The honest bottom line, echoed by independent reference sources, is that goldenseal is not recommended: any benefits appear small and can be achieved in better-studied ways. IARC. Hydrastis canadensis monograph. Open Source ↗

7. What Goldenseal Is & Where It Comes From

Key Takeaway

Goldenseal is not a food — historically it was a yellow dye. It comes from a slow-growing North American woodland plant whose root is harvested, which is part of why the plant is now threatened in the wild.

Unlike many herbs, goldenseal has no role as a food. It was historically valued as a yellow dye as much as a medicine, and there is no dietary intake level for it. IARC. Hydrastis canadensis monograph. Open Source ↗

It grows in the shaded hardwood forests of eastern North America and is slow to mature. Because the medicinal part is the root, harvesting kills the plant — a key reason wild goldenseal has become threatened and why responsibly cultivated, forest-grown goldenseal is the better choice (Section 10). NCCIH. Goldenseal. Open Source ↗

8. Body Systems It's Linked To

Key Takeaway

Goldenseal mainly acts in the digestive tract (where its compounds stay), and it affects the liver's drug-processing system. It also touches the blood (the bilirubin issue) and the heart — both reasons for the safety cautions.

The systems most relevant to goldenseal are:

The digestive tract. Because so little is absorbed, goldenseal's compounds act mostly in the gut — the basis for its traditional use as a digestive bitter and local antiseptic. Mandal SK, et al. Pharmacol Res. 2020. Open Source ↗
The liver's drug-processing system. Goldenseal slows key liver enzymes that break down medicines — the source of its interactions. Chatterjee P, Franklin MR. Drug Metab Dispos. 2003. Open Source ↗
The blood and the heart. Berberine can affect how bilirubin is carried in the blood (the newborn risk) and, at high doses, the heart's rhythm — both reasons for the cautions in Section 3. Chan E. Biol Neonate. 1993. Open Source ↗

These are general, structure-and-function descriptions — these are not medical claims about these systems.

9. Frequently Asked Questions

What is goldenseal used for?

Goldenseal is a traditional herb marketed for colds and "immune support," as a "natural antibiotic," and for digestion. Honestly, good studies don't support those uses, and its most reliable effect in people is actually a drug interaction — it changes how the body processes many medicines. It's a traditional herb, not a remedy for any specific health problem. NCCIH. Goldenseal. Open Source ↗

Does goldenseal actually work?

For its popular uses, the evidence is weak to absent. Independent reviewers find no good human studies showing goldenseal helps with colds or "immunity," and one well-known reference source lists it as "not recommended." Its local use as a digestive bitter or antiseptic is plausible but unproven. The one thing clearly shown in people is that it interacts with medicines — which is a safety point, not a benefit. Gurley BJ, et al. Mol Nutr Food Res. 2008. Open Source ↗

Can I use goldenseal in pregnancy or while breastfeeding?

No. Goldenseal must be avoided entirely in pregnancy, breastfeeding, and in babies. It can stimulate the uterus, and its compound berberine can cause a dangerous form of newborn jaundice that may injure the brain — there's even a report of an infant death after it was applied near a baby. This is one of the clearest "do not use" situations for any herb. Drugs and Lactation Database (LactMed). Open Source ↗

Does goldenseal interact with medicines?

Yes — this is the most important thing to know. Goldenseal slows two of the body's main drug-processing enzymes, which can raise the levels of many prescription medicines, including some with a narrow safety margin (such as anti-rejection medicines, blood thinners, and certain heart medicines). Always tell your provider and pharmacist you're taking it. Wu X, et al. Eur J Clin Pharmacol. 2005. Open Source ↗

Will goldenseal help me pass a drug test?

No — this is a myth. The belief traces back to a 1900 novel, not to science. Goldenseal does not "mask" drugs in urine; any apparent effect is just dilution, and modern laboratories can actually detect goldenseal's compounds in a urine sample — some even treat their presence as a sign of tampering. NCCIH. Goldenseal. Open Source ↗

Is goldenseal the same as a berberine supplement?

No. Berberine is one of goldenseal's compounds, but goldenseal delivers only a small amount of it, and oral berberine is barely absorbed (under 1%). So the berberine effects people read about (for blood sugar, for example) do not transfer to ordinary goldenseal use. If you specifically want berberine, goldenseal is not the way to get it — discuss that with your provider. Mandal SK, et al. Pharmacol Res. 2020. Open Source ↗

How do I choose a good goldenseal product — and is it endangered?

Quality and sourcing both matter a lot. Goldenseal is frequently mislabeled or substituted with cheaper plants, and testing has found some products with too little of the real herb and even with lead — so look for third-party testing (USP, NSF, or similar). It's also a threatened wild plant listed for international trade protection, so choose forest-grown or cultivated goldenseal. Wallace ED, et al. Food Chem Toxicol. 2018. Open Source ↗

10. Choosing a Quality Product

Key Takeaway

Goldenseal is one of the most adulterated herbs on the market, and some products have contained lead. It's also a threatened wild plant. Look for third-party testing and for forest-grown or cultivated sourcing.

Because goldenseal is valuable, it's a frequent target for adulteration — products are often substituted with cheaper plants that contain berberine. The compounds hydrastine and canadine are what confirm true goldenseal. Independent testing has found that nearly half of berberine/goldenseal products had problems, including two goldenseal products contaminated with lead and one with almost no berberine compared with its label. Wallace ED, et al. Food Chem Toxicol. 2018. Open Source ↗

What to Look For

Clear identity: the product should name Hydrastis canadensis and ideally confirm hydrastine/canadine content
Third-party testing: USP, NSF, or an equivalent program for identity and contaminants
Heavy-metal testing: screening for lead and other contaminants
Sustainable sourcing: forest-grown or cultivated (look for forest-grown verification), since wild goldenseal is threatened
Honest labeling: avoid products that make cure-or-prevention health claims, "boost immunity," or "pass a drug test" — those claims aren't supported or legal

On sustainability: goldenseal is listed on a major international trade-protection treaty and is classed as Vulnerable on the global Red List, because its slow growth and root harvest make wild populations easy to deplete. Choosing cultivated or forest-grown goldenseal helps protect the wild plant. IARC. Hydrastis canadensis monograph. Open Source ↗

11. Your Genes, Medicines & Goldenseal

Key Takeaway

This is the section that matters most for goldenseal. It slows the same liver enzymes your body uses to clear many medicines — in effect making a "fast" processor behave like a "slow" one. And one inherited condition, an inherited red-blood-cell condition, makes goldenseal unsafe.

Goldenseal interacts with your body's drug-processing system in a way that's worth understanding. Two enzymes — known as CYP3A4 and CYP2D6 — handle the breakdown of a large share of prescription medicines. Goldenseal slows both, which can effectively shift a person who normally clears a medicine quickly toward clearing it slowly, raising that medicine's level in the blood. This is why the interaction can matter even at modest goldenseal doses. Nguyen JT, et al. Drug Metab Dispos. 2020. Open Source ↗

There's also a genuine genetic point: people with an inherited red-blood-cell condition — an inherited condition that affects red blood cells — should avoid goldenseal, because berberine can trigger red blood cells to break down. If you know you have this condition (it's more common in some family backgrounds), goldenseal is not for you. IARC. Hydrastis canadensis monograph. Open Source ↗

12. Traditional Roots

Key Takeaway

Goldenseal is an Indigenous North American medicine, used by several Native nations as a remedy, a yellow dye, and an insect repellent — with an eyewash being one of its oldest uses. Later, Eclectic physicians made it a staple "mucous-membrane tonic."

Goldenseal has deep roots in Indigenous North American medicine. The Cherokee, Catawba, Iroquois, and Kickapoo, among others, used it as a medicine, an insect repellent, and a yellow dye for cloth and skin — and a wash for sore eyes is one of its oldest and most enduring traditional uses. In the 1800s, the Eclectic physicians adopted "hydrastis" as a "mucous-membrane tonic" and an antiseptic and astringent. IARC. Hydrastis canadensis monograph. Open Source ↗

As Section 6 explains, the local antiseptic and digestive-bitter uses are biologically plausible, while the broader systemic and "immune" claims are not supported by modern studies. Tradition is part of goldenseal's story — but it isn't the same as proof. NCCIH. Goldenseal. Open Source ↗

13. Story Behind the Science

Key Takeaway

Goldenseal went from Indigenous medicine to a 19th-century pharmacy staple, then to a famous drug-test myth born in a 1900 novel — and finally to the modern era, where its big scientific story is its drug interactions and its conservation status.

A naturalist first recorded Cherokee use of goldenseal in 1798, and through the 1800s it became a staple of American pharmacy, listed in official drug references for decades. In 1851 a chemist isolated hydrastine from the root. In 1900, a novel planted the false idea that goldenseal could fool a drug test — a myth that still circulates today. IARC. Hydrastis canadensis monograph. Open Source ↗

The modern chapters are different in character: international trade protection beginning in 1997 (reflecting conservation concern), and a series of careful clinical studies in the 2000s that established goldenseal as a significant interactor with medicines. Those two themes — conservation and drug interactions — are where goldenseal's real present-day story lies. Gurley BJ, et al. Clin Pharmacol Ther. 2008. Open Source ↗

14. Lab Tests

Key Takeaway

There's no blood test for goldenseal itself. The lab issues that matter are practical: it can affect the levels of medicines (so those may need monitoring), and — contrary to the myth — it can actually be detected in a urine drug test.

Goldenseal is not a nutrient, so there's no "goldenseal level" measured in clinical care. IARC. Hydrastis canadensis monograph. Open Source ↗

Where labs come in is through safety and interactions. If you take a medicine that needs blood-level monitoring (such as certain anti-rejection medicines or blood thinners), your provider may watch those levels more closely while you use goldenseal. And it's worth repeating: a urine drug screen can detect goldenseal's compounds — it does not hide other substances, so it cannot help "pass" a test. Gurley BJ, et al. Mol Nutr Food Res. 2008. Open Source ↗

✓ Last Reviewed: June 2026

Goldenseal (Hydrastis canadensis)

Technical Data

Clinical reference for healthcare professionals

CLINICAL SUMMARY

Goldenseal (Hydrastis canadensis)

Rhizome/root of Hydrastis canadensis L. (Ranunculaceae). Isoquinoline alkaloids (−)-β-hydrastine and berberine (plus canadine); hydrastine/canadine are the species-unique identity markers (berberine is shared across barberry, Oregon grape, Coptis, Phellodendron). Clinically notable not for efficacy but as the most significant herbal cytochrome-P450 perpetrator. Berberine ≠ goldenseal: oral berberine bioavailability is <1% and goldenseal delivers <30 mg berberine/serving, so systemic berberine effects (glucose, lipid, heart-rhythm) do not transfer to oral goldenseal.

Overall Evidence

INSUFFICIENT

What Has Been Studied

ESTABLISHEDHerb–drug interaction · CYP2D6 (~50% in vivo) and CYP3A inhibition — a SAFETY signal, not a benefit
INSUFFICIENTCommon cold / upper-respiratory / "immune" · no rigorous human studies; judged not recommended
LOWGI / local antiseptic · mechanistic plausibility (berberine); not clinically validated for the crude herb
MYTH / NULL"Blood sugar / detox / drug-test masking" · berberine effects don't transfer; masking is a myth

Standard Intake Range

No established effective dose. Traditional dried root 4–6 g/day, or 250–500 mg TID of extract standardized to 5–12% alkaloids; tincture 2–4 mL TID
The studied dose (~3 g/day) is the same dose that produces the CYP interaction; products vary widely
Cycle ≤ 3 weeks. Not recommended <18; absolutely off-limits in pregnancy, lactation, and neonates

Key Safety Flags

🔴 AVOID Pregnancy / lactation / neonates — berberine bilirubin-albumin displacement → kernicterus risk (documented infant death); uterine stimulant
🔴 AVOID G6PD deficiency (an inherited red-blood-cell condition) — risk of hemolysis (red-cell breakdown)
🔴 AVOID Narrow-therapeutic-index CYP3A4/2D6 substrates — immunosuppressants (cyclosporine/tacrolimus/sirolimus), warfarin, certain heart medicines
🟠 CAUTION Most prescription medicines — CYP3A4/2D6 inhibition can raise drug levels (the central hazard)
🟠 CAUTION Cardiovascular / blood-pressure conditions, convulsion conditions, bleeding, liver/kidney problems, perioperative period
🟠 CAUTION May affect blood sugar — coordinate with glucose-affecting medicines

Monitoring Quick-Ref

No goldenseal assay: there is no clinical reference interval — the herb itself is not measured
Serum drug levels / INR: for narrow-index co-medications (immunosuppressants, warfarin)
Liver tests & bilirubin: as clinically indicated; blood glucose if co-used with glucose-affecting agents

⚠️ Lab Interference

The operative interaction is CYP3A4/2D6 inhibition raising co-administered drug levels — not a chemical assay artifact. Two specific points: goldenseal alkaloids are detectable in urine drug screens (masking is a myth; presence may flag tampering), and berberine's bilirubin-albumin binding can perturb bilirubin measurement. There is no assay for the herb itself.

Clinical bottom line: Goldenseal has no established systemic efficacy; its only robust human finding is a drug-interaction liability — it is the most clinically significant herbal CYP3A4/2D6 inhibitor (Gurley CYP2D6 ~50% in vivo, midazolam AUC +62%; Wu cyclosporine RCT). Crucially, berberine ≠ goldenseal (oral berberine bioavailability <1%, <30 mg/serving), so systemic berberine effects (glucose, lipid, heart-rhythm) do not transfer to oral goldenseal — the operative cardiac hazard is the CYP-mediated rise in co-administered drug levels. Absolute do-not-use situation in pregnancy, lactation, and neonates (kernicterus via bilirubin displacement) and in an inherited red-blood-cell condition. Substantial product-quality (adulteration, lead) and conservation (CITES Appendix II; IUCN Vulnerable) concerns. Independent bodies (NCCIH, Merck) judge it not recommended.

1. Chemical Identity & Forms

Key Takeaway

Hydrastis canadensis L. (Ranunculaceae), monotypic genus; rhizome/root. Marker alkaloids: (−)-β-hydrastine (~1.5–4%) and berberine (~2.5%), plus canadine. Identity guardrail: berberine is cross-plant; hydrastine and canadine are goldenseal-unique. Adulteration markers (palmatine/jatrorrhizine/coptisine) are absent in true goldenseal.

Botanical name	Hydrastis canadensis L.
Family	Ranunculaceae (monotypic genus)
Part used	Rhizome and root
Common names	Goldenseal, orangeroot, yellowroot, yellow puccoon
Marker alkaloids	(−)-β-hydrastine (~1.5–4%) and berberine (~2.5%, the yellow pigment), plus canadine
Identity guardrail	Hydrastine and canadine are goldenseal-unique; berberine is cross-plant
Adulteration markers	Palmatine, jatrorrhizine, coptisine — absent in true goldenseal

Botanical identity. Hydrastis canadensis L., family Ranunculaceae; a North American woodland perennial in its own monotypic genus. Medicinal parts: rhizome and root. Common names include goldenseal, orangeroot, yellowroot, and yellow puccoon. IARC. Hydrastis canadensis monograph. Open Source ↗

Marker chemistry & identity guardrail. The characteristic constituents are isoquinoline alkaloids: (−)-β-hydrastine (~1.5–4%) and berberine (~2.5%, the yellow pigment), with canadine and minor alkaloids. Berberine is not goldenseal-specific — it is shared with Coptis, barberry, Oregon grape, and Phellodendron — so hydrastine and canadine are the chemotaxonomic markers of true goldenseal. The official assay is AOAC HPLC-UV for hydrastine + berberine; adulteration is flagged analytically by palmatine/jatrorrhizine/coptisine, which goldenseal lacks. Wallace ED, et al. Food Chem Toxicol. 2018. Open Source ↗

Forms. Root/rhizome powder (capsules/tablets — the dominant form), liquid extracts/tinctures, standardized extracts (typically 5–12% total alkaloids), topical preparations, and combination products (classically goldenseal + echinacea). The aerial parts are chemically distinct (efflux-inhibitor flavonoids rather than the root alkaloid load). Forms are not interchangeable. IARC. Hydrastis canadensis monograph. Open Source ↗

2. Mechanism of Action

Key Takeaway

Headline mechanism is CYP inhibition: methylenedioxyphenyl alkaloids form metabolic-intermediate complexes with CYP3A4 (mechanism-based inhibition) and also inhibit CYP2C9/2D6; CYP1A2/2E1 are unaffected. Pharmacodynamically, berberine is antibacterial in vitro, potentiated by within-plant aerial flavonoids that inhibit the NorA efflux pump.

Mechanism	Target	Note
CYP3A4 inhibition (mechanism-based)	CYP3A4	Time-dependent, partly irreversible
CYP2C9 / CYP2D6 inhibition	CYP2C9, CYP2D6	Hydrastine the more potent component; lowers CYP2D6/CYP3A activity by ~40–60% at ~1 g extract 3×/day for 14–28 days
Transporter inhibition	P-glycoprotein, OCT1	Hydrastine
Not affected	CYP1A2, CYP2E1	—
Antibacterial (berberine)	In vitro	Potentiated by aerial flavonoids (NorA efflux-pump inhibition)

CYP perpetrator (the headline). Goldenseal's methylenedioxyphenyl alkaloids form metabolic-intermediate complexes with CYP3A4, producing mechanism-based (time-dependent, partly irreversible) inhibition. It inhibits CYP2C9, CYP2D6, and CYP3A4 (hydrastine the more potent component), clinically reducing CYP2D6 and CYP3A activity by 40–60% after ~1 g extract three times daily for 14–28 days; CYP1A2 and CYP2E1 are unaffected, and hydrastine also inhibits P-glycoprotein and OCT1. The CYP3A effect is substrate-differential (clinically significant for midazolam, null for indinavir). Chatterjee P, Franklin MR. Drug Metab Dispos. 2003. Open Source ↗

Pharmacodynamics. Berberine is antibacterial in vitro (DNA intercalation, membrane/FtsZ disruption) but is itself a Staphylococcus aureus NorA efflux substrate, limiting standalone potency. A key within-plant synergy: the aerial-part flavonoids (sideroxylin and desmethyl-sideroxylins) inhibit the NorA efflux pump and potentiate berberine — the alkaloids themselves are not the efflux inhibitors. Other actions include antiprotozoal and antisecretory/antidiarrheal effects, all gut-localized. Junio HA, et al. J Nat Prod. 2011. Open Source ↗

3. Pharmacokinetics (ADME)

Key Takeaway

High-gut / low-systemic. Berberine oral bioavailability is ~0.4%, with extensive gastrointestinal first-pass loss; it is metabolized via CYP2D6/1A2/3A4 plus gut microbiota and undergoes enterohepatic recirculation. The decisive consequence: systemic berberine effects does not transfer to oral goldenseal at customary doses.

Absorption. Berberine has very poor oral bioavailability (≈0.4%; ~99.5% lost to gastrointestinal first-pass plus enterocyte metabolism), so goldenseal acts predominantly in the gut and as a hepatic CYP perpetrator. Hydrastine is somewhat better absorbed than berberine. Mandal SK, et al. Pharmacol Res. 2020. Open Source ↗

Distribution, metabolism & elimination. Berberine is metabolized (berberrubine, thalifendine, demethyleneberberine) via CYP2D6/1A2/3A4 and gut microbiota, undergoes enterohepatic recirculation (still ~28% of Cmax at 48 h), and distributes to the liver. Synthesis: because so little berberine is systemically available and goldenseal delivers <30 mg/serving, the systemic berberine effects discussed in the berberine literature (glucose, lipid, heart-rhythm) should not be assumed for oral goldenseal — the "berberine ≠ goldenseal" exposure gap. Mandal SK, et al. Pharmacol Res. 2020. Open Source ↗

4. Organ System Effects

Key Takeaway

Gastrointestinal (primary, local) and hepatic (the CYP-perpetrator effect) dominate. Hematologic effects (bilirubin displacement; red-cell breakdown in an inherited red-blood-cell condition) and cardiovascular effects underlie the key restrictions. A rodent-only liver-growth signal coexists paradoxically with hepatoprotection in some models.

System	Effect	Notes
Gastrointestinal	Local antibacterial / antisecretory	Primary local effect
Hepatic	CYP-perpetrator effect (not direct liver toxicity)	Rodent-only liver-growth signal (no DNA damage); not a recognized human liver toxin
Hematologic	Bilirubin displacement; red-cell breakdown in an inherited red-blood-cell condition	Underlies key restrictions
Cardiovascular	High-dose effects	Underlies key restrictions

GI & hepatic. The primary organ-level effects are gastrointestinal (local antibacterial/antisecretory) and hepatic — the latter being the clinically dominant CYP-perpetrator effect rather than direct hepatotoxicity. Goldenseal is not a recognized human liver toxin; a long-term high-dose rodent study showed liver growths (without DNA damage), while some animal models show paradoxical liver protection — neither is inferred to the human picture. IARC. Hydrastis canadensis monograph. Open Source ↗

Hematologic & cardiovascular. Berberine displaces bilirubin from albumin (the neonatal kernicterus mechanism) and can precipitate red-cell breakdown in an inherited red-blood-cell condition. Cardiovascular effects are dose-biphasic; berberine can affect cardiac rhythm at high exposure, but for goldenseal the direct risk is attenuated by <1% bioavailability — the operative hazard is the CYP3A4-mediated rise in co-administered heart-rhythm-affecting drug levels. Goldenseal is also a uterine stimulant. Chan E. Biol Neonate. 1993. Open Source ↗

5. Intake / Dose Tiers

Key Takeaway

No established effective dose. Traditional dried root 4–6 g/day, or 250–500 mg TID of 5–12% extract; tincture 2–4 mL TID; cycle ≤ 3 weeks. The "studied" ~3 g/day dose is the dose that produces the CYP interaction. Berberine non-equivalence is central.

Tier	Amount	Notes
Dietary	Not applicable	Goldenseal is not a food (historically a dye)
Traditional — dried root	~4–6 g/day	Customarily cycled ≤ 3 weeks
Traditional — extract (5–12% alkaloids)	250–500 mg, 3×/day	—
Traditional — tincture	2–4 mL, 3×/day	—
"Studied"	~3 g/day extract, short-term	The same dose that produces the CYP interaction
Berberine non-equivalence	< 30 mg berberine/serving	Berberine trials use ~500 mg — goldenseal is not a berberine substitute

5A. Dose Tiers (not efficacy-validated)

Dietary: not applicable — goldenseal is not a food (historically a dye); no dietary intake level.
Traditional: dried root ~4–6 g/day, or 250–500 mg three times daily of extract standardized to 5–12% alkaloids; tincture ~2–4 mL three times daily; customarily cycled ≤ 3 weeks.
"Studied": ~3 g/day of extract short-term — i.e., the same dose that produces the CYP interaction. No standardized effective dose is established; products vary widely.

Berberine non-equivalence. Goldenseal supplies <30 mg berberine/serving, whereas berberine trials use ~500 mg doses — reaching trial-level berberine exposure from goldenseal would require an implausible number of capsules. Mandal SK, et al. Pharmacol Res. 2020. Open Source ↗

Boundaries. Not recommended under 18, and absolutely off-limits in pregnancy, lactation, and neonates (Section 10). Discontinue ~1–2 weeks before surgery.

6. Clinical Evidence

Key Takeaway

The only robustly established human finding is the herb–drug interaction (CYP2D6 ~50% in vivo; midazolam AUC +62%; a cyclosporine RCT) — a safety signal. Cold/"immune" use is unsupported; "drug-test masking" is a myth; berberine human-trial results do not transfer to goldenseal.

Established — the herb–drug interaction. Goldenseal is the only common botanical shown to significantly inhibit CYP2D6 in vivo (~50%) and it significantly inhibits CYP3A (midazolam AUC +62%); a randomized controlled trial in 104 transplant patients found berberine markedly raised cyclosporine levels. This is the best-established goldenseal effect in humans — but a safety liability, not a therapeutic benefit. Gurley BJ, et al. Mol Nutr Food Res. 2008. Open Source ↗ Wu X, et al. Eur J Clin Pharmacol. 2005. Open Source ↗

Mixed / weak. In-vitro activity against Helicobacter pylori, an animal immunomodulation signal, and berberine's antisecretory/antidiarrheal effect in small trials — but these berberine results do not transfer to goldenseal because of the <1% bioavailability and <30 mg/serving exposure gap. Mandal SK, et al. Pharmacol Res. 2020. Open Source ↗

Null / myth. The common cold, upper-respiratory use, and "immune booster" claims are judged insufficient/ineffective by independent reviewers; "drug-test masking" is a myth that originated in a 1900 novel (modern labs detect goldenseal alkaloids in urine). One widely used reference source lists goldenseal as "not recommended." NCCIH. Goldenseal. Open Source ↗

7. Pharmacogenomics & Genetics

Key Takeaway

Goldenseal can phenoconvert CYP2D6 extensive metabolizers toward a poor-metabolizer phenotype. Berberine inhibits CYP3A4 but activates CYP3A5, so CYP3A5 genotype modulates the net effect. G6PD deficiency (an inherited red-blood-cell condition) is a pharmacogenetic vulnerability (hemolysis).

Goldenseal's CYP inhibition has a pharmacogenomic dimension: it can phenoconvert CYP2D6 extensive metabolizers toward a poor-metabolizer phenotype (genotype-dependent), and because berberine inhibits CYP3A4 while activating CYP3A5, the CYP3A5 genotype modulates the net interaction. Reported inhibition constants place berberine as the more potent CYP2D6 inhibitor and hydrastine as the more potent CYP3A inhibitor. Separately, G6PD deficiency (an inherited red-blood-cell condition) is a pharmacogenetic reason to avoid it, given the risk of berberine-associated hemolysis (red-cell breakdown). Nguyen JT, et al. Drug Metab Dispos. 2020. Open Source ↗

8. Adverse Effects

Key Takeaway

Keystone harm is neonatal kernicterus via bilirubin-albumin displacement (a documented infant death after cord-stump application). Goldenseal is a uterine stimulant and unsafe in an inherited red-blood-cell condition. High-dose effects span the nervous system, breathing, and heart. Common-dose effects are mild (GI, rash).

Effect	Severity	Notes
Severe newborn jaundice and brain injury	Keystone harm	From berberine displacing bilirubin; a documented infant death followed application to the umbilical-cord stump — must not be used in pregnancy or nursing
Uterine stimulant	Serious	A reason it must not be used in pregnancy
Red-cell breakdown	Serious	In an inherited red-blood-cell condition
High-dose: convulsions, confusion, slowed breathing, low blood pressure	High doses	—
Mild stomach upset, skin rash	Common doses	—

Keystone — neonatal kernicterus. Berberine's bilirubin-albumin displacement can cause severe neonatal jaundice and brain injury; a documented infant death followed topical application to the umbilical-cord stump. Goldenseal is a uterine stimulant, and in an inherited red-blood-cell condition it can precipitate red-cell breakdown. Chan E. Biol Neonate. 1993. Open Source ↗

High-dose & common-dose effects. High doses have been linked to convulsions, confusion/delirium, slowed breathing, and cardiovascular effects (low blood pressure/slow heart rate; a retrospective signal of raised systolic blood pressure in users), with bleeding, allergic/contact reactions, and photosensitivity also reported. Berberine can affect cardiac rhythm at high exposure, but for goldenseal this direct risk is attenuated by <1% bioavailability; the operative hazard is via drug interactions. Common-dose effects (nausea, dyspepsia, change in bowel habits, rash) are generally mild and uncommon. A 2020 advisory addressed microbially contaminated goldenseal, and homemade eyewash/eye-drop use carries contamination and injury risk. IARC. Hydrastis canadensis monograph. Open Source ↗

9. Drug Interactions

Key Takeaway

This is goldenseal's defining clinical issue. CYP3A4/2D6 (and CYP2C9) inhibition raises levels of many medicines; narrow-index substrates are the red flags — immunosuppressants, warfarin, certain heart and QT-affecting medicines. The interaction is substrate-differential. Not a meaningful nutrient depleter.

9A. By Mechanism

Cornerstone — cyclosporine. A randomized controlled trial (n=104 transplant recipients) found berberine raised cyclosporine trough by ~34.5%. Goldenseal raises midazolam AUC ~62%. By extension, expect clinically important interactions with other narrow-index CYP3A4/2D6 substrates — tacrolimus and sirolimus, CYP3A-metabolized statins, warfarin (CYP2C9 plus protein-binding displacement), some heart and QT-affecting medicines, and certain protease inhibitors and oncology agents. Separately, goldenseal can decrease the systemic exposure of a common blood-sugar medicine (metformin). The interaction is substrate-differential (significant for midazolam; null for indinavir), and the P-glycoprotein effect is unresolved (negative for digoxin). Wu X, et al. Eur J Clin Pharmacol. 2005. Open Source ↗ Nguyen JT, et al. Drug Metab Dispos. 2020. Open Source ↗

9B. Herb–Drug Interaction & Drug-Nutrient Depletion Table

Goldenseal is a botanical, not a nutrient depleter — no clinically meaningful nutrient depletion is established (a low-evidence B-vitamin/gut-flora note only). The table summarizes the clinically important herb→drug interactions.

Agent / class	Direction of effect when combined	Mechanism / severity
Immunosuppressants (cyclosporine, tacrolimus, sirolimus)	↑ drug levels (RCT for cyclosporine)	CYP3A4 + P-gp — narrow index; AVOID
Warfarin	↑ effect / bleeding risk	CYP2C9 inhibition + protein-binding displacement — narrow index; AVOID/monitor INR
CYP3A4 substrates (many — e.g., certain statins, calcium-channel blockers, midazolam)	↑ drug levels (substrate-differential)	mechanism-based CYP3A4 inhibition — MODERATE–HIGH
CYP2D6 substrates (e.g., certain beta-blockers, some antidepressants; prodrugs like codeine/tamoxifen lose activation)	↑ drug levels (or ↓ prodrug effect)	~50% in-vivo CYP2D6 inhibition
Heart-rhythm / QT-affecting medicines & macrolides	↑ levels → ↑ rhythm risk	CYP3A4-mediated; caution in vulnerable patients
Metformin (blood-sugar)	↓ metformin exposure (~25%, dose-dependent)	monitor blood glucose
Dietary nutrients	no established depletion	goldenseal is a botanical, not a depleter (low-evidence B-vitamin note only)

10. Cautions and Considerations

Key Takeaway

Absolute do-not-use situations: pregnancy, lactation, neonates/infants, newborn jaundice, and an inherited red-blood-cell condition. Cautions: narrow-index CYP3A4/2D6 substrates and most medicines, cardiovascular/blood-pressure conditions, convulsion conditions, bleeding, liver/kidney problems, blood-sugar medicines, and the perioperative period. Pregnancy/lactation: P-X / T-U.

10A. Restrictions & Cautions

Absolute do-not-use situations: pregnancy, lactation, neonates/infants, newborn jaundice, and an inherited red-blood-cell condition.
Narrow-therapeutic-index CYP3A4/2D6 substrates (immunosuppressants, warfarin, certain heart/QT-affecting medicines) — avoid; otherwise, any prescription medicine warrants provider review given the CYP-perpetrator effect.
Cardiovascular / blood-pressure conditions, a convulsion condition, bleeding problems, liver or kidney problems — caution/avoid.
Blood-sugar medicines — may affect blood sugar; monitor. Perioperative — discontinue ~1–2 weeks before surgery.

10B. Pregnancy & Lactation

P-X — Avoid entirely (do not use) Lactation transfer: T-U (unknown)

Absolutely off-limits in pregnancy and lactation. Goldenseal is a uterine stimulant with a traditional abortifacient reputation, and — decisively — berberine's bilirubin-albumin displacement creates a neonatal kernicterus risk (a documented infant death after cord-stump application). For lactation, no milk-excretion data exist, and the neonatal kernicterus concern dominates; goldenseal must not reach a neonate in any form. Drugs and Lactation Database (LactMed). Open Source ↗

Routing: direct pregnancy questions to the OB or midwife, lactation and infant-exposure questions to the pediatrician, and all interacting-medicine and narrow-index-monitoring questions to the prescriber or pharmacist. For any large accidental ingestion, contact Poison Control (1-800-222-1222). Chan E. Biol Neonate. 1993. Open Source ↗

11. Combinations & Synergy

Key Takeaway

The classic goldenseal + echinacea "cold" combination rests only on an animal signal. The mechanistically real synergy is within-plant (aerial flavonoids potentiate berberine). Avoid same-alkaloid stacking with other berberine plants and any narrow-index CYP-substrate, anticoagulant, or heart-rhythm drug.

11A. Combinations Encountered

Goldenseal + echinacea (classic "cold-season" product) — supported only by an animal immunomodulation signal, with no human trials showing benefit over either herb alone.
Within-plant synergy — aerial-part flavonoids inhibit the NorA efflux pump and potentiate berberine's antibacterial activity (a botanical-research finding, not a clinical regimen).

11B. Combinations to Avoid (Negative Stacking)

Other berberine plants (barberry, Oregon grape, Coptis, Phellodendron) — same-alkaloid stacking compounds exposure.
Narrow-index CYP3A4/2D6 substrates, anticoagulants, and heart-rhythm/QT-affecting medicines — hazardous given the CYP-perpetrator effect.
Blood-sugar-lowering agents/supplements — monitor, given possible additive effects.

Junio HA, et al. J Nat Prod. 2011. Open Source ↗

12. Lab Monitoring

Key Takeaway

No assay for goldenseal. Monitoring is driven by interactions and safety: serum drug levels/INR for narrow-index co-medications; bilirubin and liver tests as indicated; blood glucose with glucose-affecting agents. Note: goldenseal is detectable in urine drug screens (masking is a myth).

12A. Monitoring

No clinical reference interval exists for goldenseal; the herb is not a monitored analyte. Monitoring is directed at interactions and safety: check serum drug levels / INR for narrow-index co-medications (immunosuppressants, warfarin); check liver tests and bilirubin as clinically indicated; and monitor blood glucose when co-used with glucose-affecting agents. Wu X, et al. Eur J Clin Pharmacol. 2005. Open Source ↗

12B. Lab Interference

Test	Interferent	Effect / mitigation
Urine drug screen	Goldenseal alkaloids	Detectable by HPLC-UV; does NOT mask other substances (masking is a myth); presence may flag tampering
Serum bilirubin	Berberine (bilirubin-albumin binding)	May perturb measured bilirubin; clinically relevant chiefly in neonates
Therapeutic drug levels / INR (CYP3A4/2D6/2C9 substrates)	Goldenseal (CYP inhibition)	Co-administered drug levels may rise; monitor narrow-index agents
Goldenseal / alkaloid level	—	No clinical assay exists; the herb itself is not measured

13. Traditional Medicine

Key Takeaway

An Indigenous North American medicine and dye, adopted by 19th-century Eclectic physicians as a "mucous-membrane tonic." Local antiseptic and digestive-bitter uses are plausible; systemic, "immune," and cold claims are unproven.

Goldenseal is one of the broadest traditional catalogues among North American botanicals. Indigenous peoples (Cherokee, Catawba, Iroquois, Kickapoo, among others) used it as a medicine, an insect repellent, and a yellow dye, with an eyewash among its oldest and most enduring uses; 19th-century Eclectic physicians made "hydrastis" a staple "mucous-membrane tonic," antiseptic, and astringent. Evenhandedly: the local antiseptic/astringent and gastrointestinal-bitter uses are mechanistically plausible (berberine's antibacterial and antisecretory activity), whereas the systemic, immune, and cold claims are unproven. IARC. Hydrastis canadensis monograph. Open Source ↗

14. Quality Control

Key Takeaway

Goldenseal is a high-value adulteration target; hydrastine/canadine confirm identity (substituents add palmatine/jatrorrhizine/coptisine). Independent testing found ~45% of products had problems, including lead. It is also a threatened species (CITES Appendix II; IUCN Vulnerable) — sustainable sourcing matters.

Adulteration & contamination. Because of its value, goldenseal is frequently substituted with cheaper berberine-containing plants; metabolomic screening of commercial products found several adulterated, with hydrastine and canadine serving as authenticity markers (and palmatine/jatrorrhizine/coptisine signaling substitution). Independent testing found nearly 45% of berberine/goldenseal products had problems, including two goldenseal products contaminated with lead and one with almost no berberine versus label; regulators have also acted on microbial contamination. Verification routes include USP, NSF, ConsumerLab, and forest-grown verification. Wallace ED, et al. Food Chem Toxicol. 2018. Open Source ↗

Sustainability. Goldenseal is listed on CITES Appendix II and is classed as Vulnerable on the IUCN Red List; its slow growth, low fecundity, and root harvest (which kills the plant) make wild populations easy to deplete. Conservation responses include forest-farming, FairWild certification, and export monitoring — so cultivated or forest-grown goldenseal is the responsible choice. IARC. Hydrastis canadensis monograph. Open Source ↗

✓ Last Reviewed: June 2026